Head & Neck Cancer
Participant recruitment strategy outlined
Published in Cancer Weekly, August 30th, 2005
According to a study from the United States, "The purpose of this analysis was to demonstrate that the National Cancer Institute (NCI) Community Clinical Oncology Program (CCOP) will result in accruals to national research protocols for patients with malignancies in a community-based teaching hospital."
"We retrospectively reviewed the records of oncology patients eligible for clinical trials referred to the Helen F. Graham Cancer Center (HFGCC). The average number of patients who actually enroll in clinical trials nationally is 2.5%," calculated R.L. Witt and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-08-30)
More Articles from Cancer Weekly
- Colorectal Cancer
Genomic aberrations in MSH2 and MLH1 frequently occurred in Chinese CRC - Leukemia
Periconceptional vitamin use reduced leukemia risk in children with DS - Malignant Melanoma
Phx-3 induces antitumor activity against malignant melanoma cells - Ovarian Cancer
PCR used to diagnose peritoneal tuberculosis mimicking ovarian cancer - Acute Care
Clinical pathway to improve care of nearly dying oncology inpatients assessed - Adenocarcinoma
Transformed bronchioalveolar stem cells give rise to adenocarcinoma - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
